Reducing uric acid as a means to prevent cardiovascular and renal disease

Author： Watanabe Susumu Kanellis John Nakagawa Takahiko Han Lin Ohashi Ryuji Lan Hui Feng Lili Johnson Richard J

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.2, 2002-02, pp. : 193-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Folic acid does not prevent cardiovascular disease

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Uric Acid and the Kidney: Urate Transport, Stone Disease and Progressive Renal Failure

Current Pharmaceutical Design, Vol. 11, Iss. 32, 2005-12 ,pp. : 4153-4159

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2432-2438

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Uric Acid and Risk of Coronary Heart Disease

Current Pharmaceutical Design, Vol. 11, Iss. 32, 2005-12 ,pp. : 4125-4132

Bentham Science Publishers

Access to resources Recommend Favorite

Reducing effect of mangiferin on serum uric acid levels in mice

By Niu Yanfen Lu Wei Gao Lihui Lin Hua Liu Xu Li Ling

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 9, 2012-09 ,pp. : 1177-1182

Informa Healthcare

Access to resources Recommend Favorite